| NCT ID | NCT07225491 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Condition | Spine Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2025-11-24 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2025-11-24 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational study to evaluate hardware related and oncologic outcomes in adult patients with primary and metastatic spine disease undergoing separation surgery followed by radiation treatment.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of primary or metastatic disease to the spine who undergo surgical decompression and stabilization followed by radiation therapy Exclusion Criteria: * Inability to obtain a standard MRI or CT / CT myelogram for radiation treatment planning and dosimetry * Inability to receive radiation treatment. * Patients under 18 years of age
Contact & Investigator
James B Elder, MD
PRINCIPAL INVESTIGATOR
Ohio State University
Frequently Asked Questions
Who can join the NCT07225491 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spine Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07225491 currently recruiting?
Yes, NCT07225491 is actively recruiting participants. Contact the research team at Courtney.Wright@osumc.edu for enrollment information.
Where is the NCT07225491 trial being conducted?
This trial is being conducted at Indianapolis, United States, Baltimore, United States, Ann Arbor, United States, New Brunswick, United States and 1 additional location.
Who is sponsoring the NCT07225491 clinical trial?
NCT07225491 is sponsored by Ohio State University Comprehensive Cancer Center. The principal investigator is James B Elder, MD at Ohio State University. The trial plans to enroll 3,000 participants.